Official Gazettes of the U.S. Patent and Trademark Office (USPTO) sit at the headquarters' public search facility in Alexandria, Virginia, U.S., on Friday, April 4, 2014. Andrew Harrer / Bloomberg ...
A new study published in the Strategic Management Journal sheds light on how multinational firms make strategic decisions ...
Barnes & Thornburg attorneys Lauren Baker and John W. Cox examine the practical uses, benefits, and challenges of using ...
"One key issue that has arisen in funded patent litigation is transparency—in other words, to what extent must funder involvement in a patent infringement action be revealed? This article tackles this ...
While both types of litigation seek to protect innovation that often requires counsel to have specialized technical expertise—trade secret and patent cases diverge substantially in their legal ...
Last week, the Patent Trial and Appeal Board (PTAB) issued a list of FAQs related to the new bifurcated process for discretionary denial established in the March 26 memorandum issued by Acting ...
Patent litigation reform could accelerate US biosimilar market entry, which lags behind the EU due to protracted legal processes. Biosimilar manufacturers face options like pre-clearance, "at-risk" ...
An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...
This article continues our analysis of over 89,000 patents to determine how the number of office actions to allowance during prosecution impacts litigation outcomes. Last month we discussed how ...
“The factors driving perception that patents have lost their value are certainly relevant and have had a substantial impact on patent litigation [but] none of these factors, alone or in combination, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback